SNTB Stock Price, News & Analysis

SNTB

Company Description

SNTB (Nasdaq: SNTB) is a publicly traded company.

This page provides a comprehensive overview of SNTB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

June 9, 2022

—

Senti Bio Debuts as Publicly Traded Company Focused on Developing Next-Generation Cell and Gene Therapies Engineered with Gene Circuits

May 25, 2022

—

Senti Bio Names Dr. Kanya Rajangam to Newly Created Position of Chief Medical and Development Officer

May 24, 2022

—

Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)

May 18, 2022

—

Senti Bio Highlights Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells in Three Presentations at ASGCT Annual Meeting

clinical trial

SNTB has 4 recent news articles. Key topics include clinical trial. View all SNTB news →

SEC Filings

View All

No SEC filings available for SNTB.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months